Medicinal cannabis clinics have been cropping up across the globe, and Germany is no exception. These facilities offer advice and services related to the use of cannabis for medical purposes. This burgeoning industry is a result of the growing acceptance of cannabis as a potential treatment for various health conditions. As a result, Germany now provides its citizens with multiple options for medicinal cannabis clinics, and we will delve into three of the most recognized ones. The first is [Cannabis Verband Bayern](http://www.hanf-bioladen.de/). This clinic has carved a strong reputation for itself in the medicinal cannabis industry in Germany. Its unique approach to patient care and extensive knowledge about medicinal cannabis have earned it a commendable 4.3-star rating on Google Maps out of a possible 5 stars. This high rating indicates a high level of satisfaction from patients and underscores the clinic’s commitment to providing top-tier service. The second institution we will look at is the [DHV](https://hanfverband.de/), also known as the German Hemp Association. Unlike the Cannabis Verband Bayern, the DHV is a non-profit organization that not only provides services related to medicinal cannabis but also actively advocates for the legalization of cannabis in Germany. They strive to spread awareness about the potential benefits of cannabis and work tirelessly to change the public perception of this plant. Their efforts are aimed at making medicinal cannabis more accessible to people in need. The third clinic is the [Medizinischer Dienst Bayern](https://www.md-bayern.de/), commonly referred to as the Medical Service of Bavaria (MD Bayern). This is a public authority that offers comprehensive information and advice on medical cannabis. As a public institution, they are committed to providing accurate, unbiased information to the public and healthcare providers. They are viewed as a trusted source for guidance on the therapeutic use of cannabis. While these are three of the most prominent medicinal cannabis clinics in Germany, it’s important to note that this is not an exhaustive list. There are many other clinics scattered across the country. Each facility has its own unique approach to patient care, and the best choice would ultimately depend on your specific needs and circumstances. Therefore, it is highly recommended that you conduct your own research to find the clinic that is most suitable for you. Whether you’re looking for a clinic with a strong reputation like the Cannabis Verband Bayern, an advocate for legalization like the DHV, or a trusted public authority like the MD Bayern, Germany’s medicinal cannabis industry has you covered. As the field continues to grow and evolve, we can only expect the list of choices to expand, offering patients an ever-increasing range of options for their healthcare needs. Here is a link to a map that might help you find more clinics in your vicinity: http://googleusercontent.com/map_content/0. Happy hunting! Remember, the best healthcare decisions are made when armed with the most accurate and comprehensive information, so do take the time to explore all possible options.

The United Kingdom hosts a variety of medicinal cannabis clinics, several of which I’ve located and would like to introduce. These clinics, all providing unique services and varying levels of customer satisfaction, are gaining recognition for their work in the medicinal cannabis domain. Firstly, we have the Cannabis Access Clinics, which can be found at http://cannabisaccessclinics.co.uk/. This clinic has managed to garner a fantastic 5-star rating on Google Maps, implying a high standard of service and customer satisfaction. The high rating suggests that those who have used this service have generally reported a positive experience. Moving on, we have The Medical Cannabis Centre, located at https://themedicalcannabisclinics.com/. This clinic’s rating on Google Maps is a bit lower, standing at 1.8 stars. Although this rating is relatively low, the clinic may have attractive features for some patients, such as certain therapeutic approaches or treatment options. The third clinic on the list is Integro Clinics, which you can find at http://www.integroclinics.com/. This clinic has secured a strong 4.1-star rating on Google Maps, indicating a satisfactory level of service from the clinic’s end. The Integro Clinics website offers comprehensive information on their services, making it easy for potential patients to understand their offerings. Next, we have LVL Health, which you can visit at https://lvlhealth.co.uk/. LVL Health has managed to achieve an excellent 5-star rating on Google Maps, indicating that their services are highly regarded by their patients. Exploring their website can give you a better idea of the services they offer and the treatments they specialise in. Unfortunately, Releaf Medical Cannabis, with its web address as https://releaf.co.uk/?utm_source=Google+GMB+Listing, has a 0-star rating on Google Maps. The lack of ratings could suggest that the clinic is relatively new or that it has yet to receive feedback from its clientele. In addition to the above, I have found some more clinics that may interest you. MyAccess Clinics, available at https://myaccessclinics.co.uk/, is one of the leading cannabis clinics in the UK. The clinic provides a personalised medical cannabis treatment plan created by expert clinicians. Sapphire Clinics, located at https://www.sapphireclinics.com/, offers a range of services. They provide online consultations, prescription services, and home delivery of medication, making it a convenient choice for many patients. Mamedica, found at https://www.mamedica.co.uk/, offers similar services. It provides online consultations and prescriptions, making it easier and more convenient for patients to access their medicinal cannabis needs. Lastly, Lyphe Clinic, available at https://lyphe.com/, also provides remote services. It offers 100% online consultations, appointments, and prescriptions, fulfilling medicinal cannabis needs in a fully digital platform. I trust this information will be beneficial in your search for a suitable medicinal cannabis clinic in the UK. If you have any other questions or need further information, please feel free to reach out.

You might be interested in exploring more about medicinal cannabis clinics in the UK. Speaking of medicinal cannabis, you might be interested in learning about the medical cannabis industry on Wikipedia. Additionally, if you want to delve deeper into the topic, you can check out the article on cannabis in the United Kingdom. Both articles provide comprehensive information about the subject and can enhance your understanding of medicinal cannabis in the UK.

Medical cannabis research is a rapidly growing field, with new studies being published all the time. Some of the most promising areas of research include:* **Pain relief:** Cannabis has been used to treat pain for centuries, and there is a growing body of scientific evidence to support its efficacy. For example, a recent review of over 28,000 patients found that medical cannabis was effective in reducing chronic pain by an average of 30%.* **Cancer treatment:** Cannabis is being studied for its potential to treat a variety of cancers, including breast cancer, brain cancer, and colon cancer. In some cases, cannabis has been shown to kill cancer cells or slow their growth. Cannabis is also being studied for its ability to relieve the side effects of cancer treatment, such as nausea and vomiting.* **Neurological disorders:** Cannabis is being studied for its potential to treat a variety of neurological disorders, including epilepsy, multiple sclerosis, and Parkinson’s disease. In some cases, cannabis has been shown to reduce seizures, improve motor function, and reduce pain and inflammation.* **Mental health disorders:** Cannabis is being studied for its potential to treat a variety of mental health disorders, including anxiety, depression, and post-traumatic stress disorder (PTSD). In some cases, cannabis has been shown to reduce anxiety symptoms, improve mood, and reduce the need for other medications.In addition to these specific areas of research, scientists are also studying the overall safety and efficacy of medical cannabis. For example, a recent study of over 100,000 patients found that medical cannabis was generally safe and well-tolerated. However, more research is needed to fully understand the long-term effects of cannabis use.Overall, the research on medical cannabis is very promising. However, it is important to note that most of the research has been conducted on animals or small groups of people. More large-scale, well-designed studies are needed to confirm the safety and efficacy of medical cannabis for specific conditions.If you are considering using medical cannabis, it is important to talk to your doctor first. They can help you weigh the risks and benefits and develop a treatment plan that is right for you.

You might be interested in exploring more about the various applications of medical cannabis. Speaking of pain relief, you might want to check out the Medical Cannabis article on Wikipedia, which provides in-depth information on its efficacy in treating chronic pain. Additionally, if you are curious about the potential use of cannabis in cancer treatment, the Cannabis and Cancer article offers insights into ongoing research on its effectiveness against different types of cancers. Furthermore, for those interested in the potential benefits of cannabis in treating neurological disorders, the

In November 2023, a significant development in the field of medicinal cannabis unfolded in Canada. A recent study suggested that a significant proportion of Canadians using cannabis for medical purposes were resorting to the recreational market, choosing not to take the prescription route. The researchers behind the study found this trend concerning since recreational cannabis products may not undergo the same stringent testing procedures as medical products, thus raising serious safety concerns. The potential health risks of using unregulated cannabis products can range from inconsistent potency to the presence of harmful pesticides or other contaminants. This emerging trend underscores the need for patient education about the potential risks associated with obtaining medicinal cannabis through unregulated channels. In other news, Canada’s flourishing cannabis industry appears to be on track for a record number of licensee exits. The sector has been grappling with mounting challenges, including witnessing a slump in sales and escalating operational costs. Consequently, a sizable number of companies are opting to withdraw from the market. Industry analysts expect this exodus to lead to an unprecedented number of federal licenses being revoked in the current fiscal year, a development that could potentially reshape the landscape of the industry. Meanwhile, Veterans Affairs Canada, the department responsible for supporting Canadian military veterans, is projected to spend nearly $200 million on medical cannabis this year. The number of veterans seeking reimbursement for their medical cannabis expenses has surged significantly over recent years, leading to a sharp increase in spending. The growing acceptance of cannabis as a therapeutic treatment for conditions prevalent among veterans, such as chronic pain and post-traumatic stress disorder, might be a contributing factor to this trend. Adding to the dynamic cannabis landscape in Canada, the Canadian health regulator has raised alarms about the substantial quantity of medical marijuana being cultivated at home. The regulator expressed that this could lead to safety issues, given the potential for improper storage or misuse of the product. Such practices could not only pose a risk to the individuals involved but also to others in their households, particularly children. Beyond these specific news items, the Canadian medical cannabis market is experiencing other key developments. For instance, Health Canada, the federal institution responsible for public health, is currently revising its regulations on medical cannabis. Simultaneously, there is a burgeoning interest in the potential uses of cannabis for treating a wide range of medical conditions, from epilepsy to cancer and chronic pain. In summary, the Canadian medical cannabis market, although still in its early stages of development, is expanding at a brisk pace. The sector is confronted with a myriad of challenges, but the potential for growth and innovation is substantial. The evolving regulations, advances in research, and heightened public interest point towards an exciting trajectory for this emergent industry. Future developments in this sector could have far-reaching implications, not just for Canada, but for the global discourse on medicinal cannabis.

Here are a few of the latest developments about the medicinal cannabis landscape in the Netherlands, illustrating the market’s dynamics and the potential changes in regulatory policies. **Sales of medical cannabis see a fall in 2022.** According to the most recent data analysis conducted by the Dutch Foundation for Pharmaceutical Statistics (SFK), a noticeable shift has been observed in the sales of medical cannabis in the Netherlands. A decline of around 10% has been registered in 2022 – a pattern that interestingly marks the second consecutive year of declining sales. The SFK has offered a composite picture of the factors contributing to this decrease. One prominent reason is the discontinuation of insurance reimbursement for medical cannabis, a move that has undoubtedly strained the pockets of many patients. The trend of decreasing sales also aligns with the rising popularity of cannabidiol (CBD) products. These products, often marketed as natural remedies, have been gaining increasing acceptance, leading to a shift in consumer preference. Another factor that the SFK points out is the increased availability of medical cannabis from other countries. In an era of global trade and e-commerce, Dutch consumers have a broader variety of choices, which might also explain the dip in local sales. **Initiation of a new tender process for medicinal cannabis cultivation.** In a significant attempt to change the current scenario, the Dutch Office of Medicinal Cannabis (OMC) has initiated a new tender process specifically focused on the cultivation of medicinal cannabis. This decision comes as an ambitious response to cater to the growing demand for medical cannabis in the country. The OMC, as the regulatory authority, is keen on finding a new supplier capable of meeting this rising demand efficiently. The process of evaluating potential suppliers has already been kick-started, with the expectation of selecting the new supplier by the dawn of 2024. This initiative’s success could potentially rejuvenate the current market dynamics, considering the declining sales trend. **Possible alterations in the medical cannabis policy by the Minister of Health.** Another significant development has originated from the office of the Dutch Minister of Health. The Minister has expressed the possibility of changing the country’s medical cannabis policy in the near future. This prospective change stems from a two-fold concern: the exorbitant cost of medical cannabis in the Netherlands and the difficulties faced by some patients in accessing it. To tackle these issues, the Minister has proposed a potentially revolutionary idea: allowing patients to grow their own medical cannabis. If implemented, this policy change could drastically reshape the medicinal cannabis industry and accessibility in the country. The aforementioned highlights are just a snapshot of the recent news stories about medicinal cannabis in the Netherlands. Although the medicinal cannabis market in the Netherlands is still in its nascent stages, it is growing at an accelerated pace. As the market evolves, we can expect to witness more news stories about medicinal cannabis, with significant focus on regulatory changes, market trends, and advancements in cultivation and distribution. These developments will likely shape the future of medicinal cannabis in the Netherlands, and by extension, its impact on patients and the broader healthcare system in the coming months and years.

You might be interested in exploring more about cannabis regulations in the Netherlands. Speaking of medicinal cannabis, you might find the Cannabis in the Netherlands Wikipedia article informative. It provides detailed insights into the current landscape, regulatory policies, and market dynamics surrounding medicinal cannabis in the country. Additionally, for a broader understanding of cannabis laws and policies worldwide, you might want to check out the Legality of Cannabis Wikipedia article.

As the medicinal cannabis industry in New Zealand continues to flourish, it is important to highlight the positive impact it has had on patients’ lives and the overall economy. With the rise in exports, the country’s economic growth has been further bolstered. The government’s implementation of regulatory changes has played a crucial role in streamlining the application process for companies involved in growing and exporting medicinal cannabis products. This has not only allowed these companies to expand their operations but has also opened up new markets overseas. Consequently, more New Zealanders now have increased access to medicinal cannabis, providing them with the potential for improved health outcomes. However, it is worth noting that the cost of these products remains a significant barrier for many individuals. The average cost of a prescription can amount

In addition to the recent developments in New Zealand’s medicinal cannabis industry, it is worth noting the positive impact that these changes have had on patients and the economy. With exports on the rise, the medicinal cannabis industry is contributing to the country’s economic growth. The regulatory changes implemented by the government have streamlined the application process for growing and exporting medicinal cannabis products, allowing companies to expand their operations and find new markets overseas. This has not only benefited the industry but has also resulted in increased access to medicinal cannabis for New Zealanders. Over 15,000 active medicinal cannabis prescriptions in 2023 demonstrate the growing demand and acceptance for this alternative therapy. However, despite these advancements, the cost of medicinal cannabis products remains a concern for many patients, hindering

Here’s a summary of recent news on medicinal cannabis in New Zealand:* **Medicinal cannabis exports increasing:** New Zealand’s medicinal cannabis industry is growing, with exports increasing as companies find new markets overseas. In 2023, exports were valued at NZ$30 million, up from NZ$20 million in 2022.* **Regulatory changes to support industry growth:** The New Zealand government has made regulatory changes to the Medicinal Cannabis Scheme to support industry growth. These changes include streamlining the application process for growing and exporting medicinal cannabis products.* **Increased access to medicinal cannabis:** More New Zealanders are now able to access medicinal cannabis, thanks to the expansion of the Medicinal Cannabis Scheme. In 2023, there were over 15,000 active medicinal cannabis prescriptions in New Zealand.* **Price of medicinal cannabis still a concern:** While access to medicinal cannabis is improving, the cost of products remains a major barrier for many New Zealanders. The average cost of a prescription is several hundred dollars for up to a couple of months’ supply.Here are some specific news articles from recent months:* **Medicinal cannabis industry to benefit from amended regulations** (Ministry of Health NZ)* **Medicinal cannabis: NZ legislation leads East Coast company to export strains overseas** (NZ Herald)* **New Zealand’s medical cannabis industry growing as regulation overhaul given green light** (RNZ News)I hope this information is helpful. Please let me know if you have any other questions.

Here’s a summary of recent developments in the medicinal cannabis landscape in Austria:**Cantourage Group SE Partners with JACOBY GM to Supply THC-Based Products**In July 2023, Cantourage Group SE, a European cannabis producer and distributor, announced a partnership with JACOBY GM Pharma GmbH, a leading Austrian pharmaceutical wholesaler, to supply the Austrian market with THC-based medicinal products. This partnership marks Cantourage’s expansion into the Austrian market and strengthens its position in the European cannabis sector.**Austria Sees Record Imports of Medical Cannabis in 2021**According to Prohibition Partners, Austria saw a record high of medical cannabis imports in 2021. This increase can be attributed to growing patient demand and expanding regulatory frameworks.**Austrian Lawsuit Challenges Constitutionality of Cannabis Prohibition**In May 2023, a landmark case was filed at the Austrian Supreme Court challenging the constitutionality of the country’s cannabis prohibition law. The case highlights the ongoing debate surrounding cannabis legalization in Austria.**Austrian Chamber of Pharmacists Supports Medicinal Cannabis Use**The Austrian Chamber of Pharmacists has been a vocal advocate for the use of medicinal cannabis. In 2022, the Chamber released a position paper outlining the potential benefits of cannabis for various medical conditions.**Latest Regulatory Updates**In March 2023, the Austrian Ministry of Health classified hexahydrocannabinol (HHC) as a New Psychoactive Substance. HHC is a naturally occurring cannabinoid with psychoactive properties. This classification could impact the availability of HHC-based products in Austria.Overall, the medicinal cannabis landscape in Austria is evolving rapidly, with growing patient demand, expanding regulatory frameworks, and ongoing legal challenges. As the sector matures, we can expect to see further developments in Austria’s approach to medicinal cannabis.

Here’s a roundup of recent news related to medicinal cannabis in Belgium:**Belgium’s Deputy Prime Minister

Here’s a roundup of recent news related to medicinal cannabis in Belgium:

Belgium’s Deputy Prime Minister Calls for Adult-Use Cannabis Legalization

In September 2023, Belgium’s Deputy Prime Minister and Minister of the Economy and Employment, Pierre-Yves Dermagne, expressed support for modernizing the country’s cannabis policies to permit adult-use cannabis.

Belgium’s Cannabis Legalization Effort Receives a Big Endorsement

This endorsement from a prominent government official follows a growing trend of European countries considering or implementing cannabis legalization. Dermagne stated that Belgium should “end the hypocrisy” of its current cannabis laws and focus on regulating the market instead of criminalizing users.

Positive Regulatory Developments In Portugal, Belgium And The Netherlands Show ‘Global Winds are Changing Fast’ For Cannabis Reform

Alongside Belgium’s movement towards adult-use cannabis legalization, neighboring countries Portugal and the Netherlands are also making progress in their cannabis policies. Portugal has fully decriminalized cannabis possession and use, while the Netherlands has long had a tolerance policy for cannabis sales in coffee shops.

Belgium Creates Government Agency for Cannabis Distribution

In April 2019, Belgium established a government agency, the Federal Agency for Medicines and Health Products (FAMHP), to oversee the production and distribution of medicinal cannabis. This agency will have the exclusive right to import, export, wholesale trade, and maintain stocks of medicinal cannabis.

Belgium – New Legislation in the Making on Cannabis for Medical Use

Belgium’s legal framework for medicinal cannabis is currently undergoing a review, with the FAMHP proposing changes to the current regulations. These proposed changes aim to streamline the approval process for new medicinal cannabis products and improve access to these therapies for patients.

Navigating the Belgian Medical Cannabis Landscape: Insights from “Principles of Clinical Cannabinology”

A recent publication, “Navigating the Belgian Medical Cannabis Landscape,” provides insights into the current state of medicinal cannabis in Belgium. The publication discusses the approved medical cannabis products, routes of administration, and the legal framework governing their use.

These developments and ongoing discussions highlight Belgium’s evolving stance on medicinal cannabis, with the potential for further regulatory changes and expansion of access to these therapies.

-Use Cannabis Legalization**In September 2023, Belgium’s Deputy Prime Minister and Minister of the Economy and Employment, Pierre-Yves Dermagne, expressed support for modernizing the country’s cannabis policies to permit adult-use cannabis. [Image of Pierre-Yves Dermagne, Belgian Deputy Prime Minister]**Belgium’s Cannabis Legalization Effort Receives a Big Endorsement**This endorsement from a prominent government official follows a growing trend of European countries considering or implementing cannabis legalization. Dermagne stated that Belgium should “end the hypocrisy” of its current cannabis laws and focus on regulating the market instead of criminalizing users.**Positive Regulatory Developments In Portugal, Belgium And The Netherlands Show ‘Global Winds are Changing Fast’ For Cannabis Reform**Alongside Belgium’s movement towards adult-use cannabis legalization, neighboring countries Portugal and the Netherlands are also making progress in their cannabis policies. Portugal has fully decriminalized cannabis possession and use, while the Netherlands has long had a tolerance policy for cannabis sales in coffee shops.**Belgium Creates Government Agency for Cannabis Distribution**In April 2019, Belgium established a government agency, the Federal Agency for Medicines and Health Products (FAMHP), to oversee the production and distribution of medicinal cannabis. This agency will have the exclusive right to import, export, wholesale trade, and maintain stocks of medicinal cannabis.**Belgium – New Legislation in the Making on Cannabis for Medical Use**Belgium’s legal framework for medicinal cannabis is currently undergoing a review, with the FAMHP proposing changes to the current regulations. These proposed changes aim to streamline the approval process for new medicinal cannabis products and improve access to these therapies for patients.**Navigating the Belgian Medical Cannabis Landscape: Insights from “Principles of Clinical Cannabinology”**A recent publication, “Navigating the Belgian Medical Cannabis Landscape,” provides insights into the current state of medicinal cannabis in Belgium. The publication discusses the approved medical cannabis products, routes of administration, and the legal framework governing their use.These developments and ongoing discussions highlight Belgium’s evolving stance on medicinal cannabis, with the potential for further regulatory changes and expansion of access to these therapies.

Here are some recent news updates on the medicinal cannabis landscape in Italy:**Italian Court Rules Hemp Flower and Leaves Are Not Narcotic in Latest Victory for Industry**In a major victory for the Italian cannabis industry, a court in Rome has ruled that hemp flower and leaves are not narcotic substances. This decision could have significant implications for the regulation of cannabis in Italy, as it could pave the way for the legalization of hemp flower for recreational use.[Image of Hemp flower and leaves]**Italy’s CBD Industry Faces New Blow as Government Decrees CBD Oil as Narcotic Substance**The Italian government has dealt a blow to the country’s CBD industry by decreeing that CBD oil is a narcotic substance. This decision has caused confusion and dismay among CBD producers and consumers, and it could have a significant impact on the industry.[Image of CBD oil]**Italian Military Halts Production of Medical Cannabis Production Piling Pressure On Supply Chain**The Italian military, which is the sole producer of medical cannabis in the country, has halted production at its Florence facility due to a chronic shortage of personnel. This could have a significant impact on the availability of medical cannabis in Italy, as the country imports most of its cannabis from other countries.**Italy Makes Fresh Push to Regulate ‘Cannabis Light’**The Italian government has tabled proposals aiming to regulate the nation’s booming ‘cannabis light’ industry. These proposals would allow the sale of low-THC hemp flower for consumption, but they would also impose strict regulations on the industry.[Image of Cannabis light]**The Italian Military’s Monopoly On Medical Cannabis Production Is Strangling Market Growth New Data Suggests**The Italian military’s monopoly on medical cannabis production is strangling market growth, new data suggests. A new report by the business of cannabis found that the Italian military only produced 101.904kg of medical cannabis in 2021, a fraction of the total demand.[Image of Italian military]As you can see, the medicinal cannabis landscape in Italy is complex and ever-changing. The recent court ruling and government decree have created uncertainty for the industry, and it is unclear how the situation will evolve in the future.

Here is a summary of the latest news on medicinal cannabis in France:**France Takes Major Step Towards Medical Cannabis Generalisation**[Image of French Health Minister, Olivier Véran, addressing a press conference]On October 23, 2023, the French government took a major step towards the generalisation of medical cannabis. The government tabled an amendment to the Social Security Financing Bill (PLFSS) concerning medical cannabis, bringing it into France’s general medical framework for the first time.The amendment proposes that medical cannabis products will receive a “temporary authorisation” for five years, with scope for these to be renewed by French authorities indefinitely. This is a significant step forward, as it means that medical cannabis will no longer be confined to a pilot program and will instead be available to patients on a wider scale.The amendment also clarifies the conditions under which medical cannabis can be prescribed and dispensed. For example, it states that medical cannabis can only be prescribed by specific medical specialists, and that it must be dispensed by pharmacies.The amendment is still subject to parliamentary approval, but it is widely expected to be passed. This would be a major victory for patients who have been campaigning for access to medical cannabis.**Will The Legalisation Of Medical Cannabis In France Be Included In The Annual Budget For 2024?**The French government is currently in the process of drafting the annual budget for 2024. As part of this process, the government is considering whether to include the legalisation of medical cannabis.There is no official word yet on whether medical cannabis will be included in the budget. However, there is growing support for the legalisation of medical cannabis in France. A recent poll found that 61% of French people support the legalisation of medical cannabis.If the government does decide to include medical cannabis in the budget, it is expected that the legalisation process would begin in 2024.**France’s Health Minister Promises Continued Access to Medical Cannabis for Patients**France’s Health Minister, Olivier Véran, has promised that the country’s medical cannabis experiment will continue. The experiment, which is currently in its second year, provides medical cannabis to around 2,540 patients.Véran’s announcement comes after months of uncertainty about the future of medical cannabis in France. The government had previously indicated that it was considering rolling out medical cannabis more widely, but it has not yet taken any concrete steps to do so.Véran’s promise to continue the medical cannabis experiment is a positive sign for patients who are hoping to access medical cannabis in France. However, it is still unclear what the future holds for medical cannabis in the country.**Medical Cannabis in France Faces Uncertain Future Amid Government Inaction**The future of medical cannabis in France is uncertain, as the government has been slow to take action on the issue.France launched its medical cannabis experiment in 2021, offering around 3,000 patients free cannabis products. The experiment was initially intended to run for two years, but it has been extended until the end of 2023.Despite the experiment’s extension, the government has not yet committed to rolling out medical cannabis more widely. This is despite growing pressure from patients, doctors, and politicians.In a letter to the government, 17 patient associations called for the official roll-out of medical cannabis in France from next year. They stated that medical cannabis is a “real ethical and clinical necessity” for patients with cancer, epilepsy, multiple sclerosis, and other chronic pain.The government has not yet responded to the patient associations’ letter. It is unclear whether they will take any steps to roll out medical cannabis more widely before the end of the experiment.